O-acyltransferase like, pseudogene (OACYLP)

O-acyltransferase like, pseudogene (OACYLP) is classified as a pseudogene and does not encode a functional protein. It is located in the human genome and has sequence similarity to genes of the acyltransferase-3 (AT3) family, which in bacteria function as membrane-bound enzymes involved in the modification of complex carbohydrates such as peptidoglycan and lipopolysaccharide[2][1][3]. However, in humans, OACYLP is annotated as a non-functional gene and is not known to produce an active acyltransferase enzyme or participate in biological processes. As a pseudogene, it is not considered a therapeutic target, does not have associated disease roles, known biological function, or interact with drugs. There are no known mechanisms of action, biomarker utilities, or safety concerns related to this gene. Key context: - Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from duplication or retrotransposition events and often accumulate mutations that prevent them from expressing functional proteins. - While the acyltransferase-3 (AT3) protein family is a bona fide molecular target in bacteria and is involved in processes such as antibiotic resistance and cell wall modification[1][3], the human OACYLP gene is not an active member of this family and does not serve these functions. - No evidence supports OACYLP as a disease target or actionable biomarker. There are no drugs that interact with this pseudogene. If you are referring to the human gene or protein for biomedical research or drug targeting, OACYLP is not considered a valid or actionable target[2]. If you need information on functional bacterial AT3 acyltransferases, those are distinct and biologically active genes/proteins[1][3].

Other names

ACYL3Pacyltransferase 3, pseudogeneOACYLP